NOVO NORDISK A/S

Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquartered in Denmark, Novo Nordisk employs approximately 45,971 employees in 79 countries as on 2021 and markets its products in more than 170 countries.

For year ending December-2021, Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

Annual Results Summary:

NOVO NORDISK A/S - Annual Results - Revenues and Net Profits - in Million DKK:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2022	176,954	74,809	55,525
Dec-2021	140,800	58,644	47,757
Dec-2020	126,946	54,126	42,138
Dec-2019	122,021	52,483	38,951
Dec-2018	111,831	47,248	38,628
Dec-2017	111,696	48,967	38,130
Dec-2016	111,780		37,925

Balance Sheet Summary

NOVO NORDISK A/S - Balance Sheet Summary - in Million DKK:

Year - Ending	Total Assets	Total Liabilities	Total Equity
Dec-2022	241,257	157,771	83,486
Dec-2021	194,508	123,762	70,746
Dec-2020	144,922	81,597	63,325
Dec-2019	125,612	68,019	57,593
Dec-2018	110,769	58,930	51,839

NOVO NORDISK A/S

NOVO NORDISK A/S - Annual Results - Revenues and Net Profits - in Million DKK:

NOVO NORDISK A/S - Balance Sheet Summary - in Million DKK:

Share it on Social Media